919-206-7900
Polarean Imaging plc.'s technology is for research use only

Corporate News

2019

12 November New System Delivery and Installation
08 November Grant of Options
07 November Completion of patient enrolment for Clinical Trials and PDMR Appointment
11 October Director Dealing
11 October Polarean notes statement from Amphion Innovations
09 October Holding(s) in Company
03 October Polarean notes statement from Amphion Innovations
25 September Polarean notes statement from Amphion Innovations
24 September Half-year Report
10 September Polarean notes statement from Amphion Innovations
10 September New System Installation
09 August Polarean notes statement from Amphion Innovations
05 August Phase III Clinical Trials update
First patient enrolment at University of Cincinnati
31 July Total Voting Rights
30 July Holding(s) in Company
30 July Holding(s) in Company
29 July Holding(s) in Company
25 July Result of AGM
24 July Exercise of Warrants
22 July Placing to raise £2.1 million
11 July New System Order
27 June Final Results
13 June Investor Symposium presentations available online
11 June Phase III Clinical Trials - Update
05 June New System Order
23 May Grant of Share Options
23 May London Investor Symposium
Wednesday 12 June 2019
21 May Third tranche of $3m paediatric lung disease imaging study grant confirmed
13 May Phase III Clinical Trial Update
30 April Total Voting Rights
29 April Appointment of Chief Financial Officer
02 April Exercise of Warrants
01 April Amphion Innovations plc - Pledge of Polarean shares
15 February New System Order with the University of British Columbia
24 January Appointment of Nominated Adviser and Broker
21 January Holding(s) in Company
03 January Holding(s) in Company